NCTN Deep South Research Consortium
NCTN 深南研究联盟
基本信息
- 批准号:9236167
- 负责人:
- 金额:$ 49.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-16 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressAlabamaAmerican College of Radiology Imaging NetworkAreaArkansasBasic ScienceCancer BiologyCancer ControlCancer PatientCancer and Leukemia Group BClinical InvestigatorClinical ResearchClinical TrialsClinical Trials Cooperative GroupCommunitiesCommunity OutreachComprehensive Cancer CenterCountryDeep SouthDetectionDiagnosisDoctor of MedicineEastern Cooperative Oncology GroupEligibility DeterminationEnsureFacultyFosteringFundingGynecologic Oncology GroupHome environmentHospitalsInstitutionIntentionInternationalInvestigational TherapiesKnowledgeLeadLeadershipLouisianaMalignant NeoplasmsMalignant neoplasm of brainMalignant neoplasm of cervix uteriMalignant neoplasm of ovaryMalignant neoplasm of pancreasMentorsMinorityMinority ParticipationMississippiNamesNational Clinical Trials NetworkNational Surgical Adjuvant Breast and Bowel ProjectNewly DiagnosedOutcomeParticipantPatientsPhasePhysiciansPrincipal InvestigatorProcessQuality of lifeRadiation Therapy Oncology GroupRecording of previous eventsRecruitment ActivityReproduction sporesResearchResearch InfrastructureResearch PersonnelResearch TrainingScientistSiteSocioeconomic StatusSouthwest Oncology GroupTrainingTraining ProgramsTraining and InfrastructureTranslatingTranslational ResearchUniversitiesVisionWorkanticancer researchcancer carecancer clinical trialcancer health disparitycancer preventioncancer riskdemographicsethnic minority populationhealth disparityinterestmalignant breast neoplasmmemberminority healthminority scientistnext generationorganizational structurepatient populationpopulation basedprogramspublic health relevanceracial health disparitysurvivorshiptranslational scientist
项目摘要
DESCRIPTION (provided by applicant): The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center (CCC) has a long history of participation within the nation's cancer related Clinical Trials Cooperative Group Program. Specifically, UAB was a founding member of the GOG, and has been a member of RTOG, ECOG, ACRIN. CALGB, NSABP, and SWOG. The UAB CCC now submits this proposal to become a Lead Academic Participating Site, specifically named the NCTN Deep South Research Consortium, in the NCI's newly restructured National Clinical Trials Network (NCTN) Program. It is our intention to continue as a leading contributor of scientific leaders and clinical trial participants to the NCTN Program in th U.S. and particularly in the Southeast. To accomplish this overall vision, we propose the following specific aims: 1) To further enhance the involvement of existing UAB CCC scientific leadership in NCTN Center related clinical and translational research and to develop the next generation of NCTN Center scientific leaders within the UAB CCC, and 2) To further refine a clinical trials process within the UAB CCC that optimizes accrual of potentially eligible cancer patients and patients at risk for cancer to NCTN Center clinical trials. We include in this proposa a detailed description of our NCI cooperative group scientific and patient accrual contributions and accomplishments, a leadership and organizational structure for our proposed Consortium, and how we intend to utilize existing UAB CCC infrastructure to achieve our aims. We also include a detailed description of our proposed Junior Investigator Recruitment and Mentoring Program.
描述(由申请人提供):伯明翰(UAB)综合癌症中心(CCC)的阿拉巴马大学在美国与癌症相关的临床试验合作小组计划中的参与历史悠久。具体而言,UAB是GOG的创始成员,并且曾是RTOG,ECOG,ACRIN的成员。 CALGB,NSABP和SWOG。 UAB CCC现在提出了这一建议,以成为NCI新重组的国家临床试验网络(NCTN)计划中的主要学术参与地点,专门为NCTN Deep South Research Consortium。我们打算继续作为美国NCTN计划的科学领导者和临床试验参与者的主要贡献者,尤其是在东南部。为了实现这一整体愿景,我们提出以下特定目的:1)进一步增强现有的UAB CCC科学领导力与NCTN中心相关的临床和翻译研究,并发展UAB CCC中的NCTN中心科学领导者的下一代科学领导者,以进一步在UAB CCC中进一步改善UAB CCC中的临床临床试验,以使癌症的癌症癌症癌症的癌症癌症和癌症癌症的癌症癌症癌症的癌症为癌症的癌症为癌症的癌症为癌症为癌症的,并在癌症中充分了癌症。我们在此提案中包括对我们的NCI合作团体科学和患者应计贡献和成就,我们提议的财团的领导和组织结构的详细描述,以及我们如何利用现有的UAB CCC基础架构来实现我们的目标。我们还提供了我们拟议的初级调查员招聘和指导计划的详细描述。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY-ANN BJORNSTI其他文献
MARY-ANN BJORNSTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY-ANN BJORNSTI', 18)}}的其他基金
2014 DNA Topoisomerases in Biology and Medicine Gordon Research Conference
2014 DNA 拓扑异构酶在生物学和医学戈登研究会议
- 批准号:
8714782 - 财政年份:2014
- 资助金额:
$ 49.78万 - 项目类别:
SUMOylation and Cell Sensitivity to Top1 Poisons
SUMO 化和细胞对 Top1 毒物的敏感性
- 批准号:
7225898 - 财政年份:2005
- 资助金额:
$ 49.78万 - 项目类别:
SUMOylation and Cell Sensitivity to Top1 Poisons
SUMO 化和细胞对 Top1 毒物的敏感性
- 批准号:
7087936 - 财政年份:2005
- 资助金额:
$ 49.78万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Center for Cancer Control in Persistent Poverty Areas (C3P2)
持续贫困地区癌症防治中心(C3P2)
- 批准号:
10660380 - 财政年份:2023
- 资助金额:
$ 49.78万 - 项目类别:
Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development
类风湿关节炎患者高脂血症管理的优化:以患者为中心的干预措施发展
- 批准号:
10443313 - 财政年份:2022
- 资助金额:
$ 49.78万 - 项目类别: